Haematococcus pluvialis astaxanthin tablet candies capable of maintaining joint and connective tissue health, and preparation method thereof

Abstract

The invention discloses haematococcus pluvialis astaxanthin tablet candies capable of maintaining joint and connective tissue health. The haematococcus pluvialis astaxanthin tablet candies capable ofmaintaining joint and connective tissue health are prepared from the following raw materials in percentage by mass: 15-30% of astaxanthin, 5-20% of isomaltitol, 10-20% of colostrum basic proteins, 0.5-2% of ginseng, 30-47% of microcrystalline cellulose, 0.5-1% of vitamin D, and 0.5-1% of vitamin C. By combining the the antioxidant astaxanthin with the ginseng, the isomaltitol, the colostrum basicproteins, the microcrystalline cellulose, the vitamin D and the vitamin C at certain proportion, the haematococcus pluvialis astaxanthin tablet candies are capable of playing complementary and synergistic effects of the raw materials, thereby achieving relatively good anti-oxidation effects; and thus, the haematococcus pluvialis astaxanthin tablet candies are capable of scavenging free radicals invivo, diminishing inflammation, resisting inflammation, improving joint flexibility, enhancing aerobic metabolism, reducing muscle pain, improving endurance, reducing muscle damage and shortening muscle injury recovery time. Moreover, the haematococcus pluvialis astaxanthin tablet candies have the advantages of being good in taste, stable in quality, rich in nutrients, significant in diet therapyeffects, convenient to carry, simple in preparation method and conducive to industrial production.

Description

technical field [0001] The invention belongs to the technical field of food production, and in particular relates to a Haematococcus pluvialis astaxanthin tablet candy for maintaining the health of joints and connective tissues and a preparation method thereof. Background technique [0002] Osteoarthritis patients in my country account for more than 10% of the total population, up to more than 100 million, and the incidence rate increases with age. The incidence trend of orthopedic diseases is not optimistic. During the 20 years from 1990 to 2010, the incidence of knee arthritis increased by 45%, and the disability rate ranked second in the world, accounting for 21.3%. Treatment costs will increase to 85 billion; by 2050 will reach 1.8 trillion. The clinical manifestations of joint diseases are swelling, pain, stiffness, hyperplasia, limited freedom of movement of patients, and even disability. The joint problems that endanger humans mainly include osteoarthritis, rheumato...

AI Technical Summary

Problems solved by technology

Although there are many health products and foods for the prevention and treatment of joint diseases on the market, there are few foods that use astaxanthin to prevent and treat joint diseases on the market, and they are basically prepared using the concept of traditional Chinese medicine treatment. To a certain extent, it can relieve pain, but the correlation between the functional ingredients and the health care function is poor, and the nutritional ingredients and therapeutic efficacy cannot meet the ideal requirements.